Clinical evaluation of herbal coded formulation Cran-off to Urixin in the treatment of Urinary tract infection

Urinary tract infections are the largest group of infections after the respiratory tract infections. in 85% of the cases the causative organism is e. coli. a clinical trial was conducted to evaluate the efficacy of coded herbal formulation cranoff (test drug) for the treatment of urinary tract infection comparing with urixin (control). one hundred and thirty patients suffering from urinary tract infection from both groups (males: 45,mean age: 34±14 and females: 85,mean age: 33±13 year,range: 15-55) were enrolled in the trial and divided in to two groups according to treatment regimens. cranoff (test drug) 500mg two capsules and urixin (pipemidic acid trihydrate jp15) (control) 400mg capsules twice daily were prescribed for 2-3 weeks. urinary tract infection was improved in 23 (35.38%) patients out of 65 patients by the use of cranoff (test drug),and in 15 (23.07%) patients out of 65 by the use of urixin (control drug). furthermore,there was a significant improvement in urinary tract infection associated clinical features as compared to urixin. it is concluded that cranoff possesses a therapeutic value for the improvement of urinary tract infection and its associated symptoms as compared to urixin.